May 2008 Volume 4, Issue 5

Volume 4, Issue 5 | May 2008

May 2008

In this Issue

Genomics & Proteomics

Drug Discovery News Placeholder Image

Exploring new territory

Celera inks two-year license agreement with Merck to develop RNAi-based therapeutics
Drug Discovery News Placeholder Image

Bringing it back home

Affymetrix extends Collaborations in Cancer Research Program to North American region
Drug Discovery News Placeholder Image

Raising hopes

Helicos enters collaboration to sequence cancer-associated genes
Drug Discovery News Placeholder Image

American Peptide launches new program

Company looks toward more consultative role

Research & Development

Drug Discovery News Placeholder Image

Synthetic biology gets a boost

Codon Devices to engineer protein drug for Merrimack Pharmaceuticals
Drug Discovery News Placeholder Image

Building better bones

Merck, Harvard to advance osteoporosis research
Drug Discovery News Placeholder Image

NIEHS, U. Minn. study may lead to improved epilepsy treatments

Researchers from the National Institute of Environmental Health Sciences (NIEHS) and the University of Minnesota have gained new insight into one of the most puzzling aspects of epilepsy treatment: why some epileptics fail to respond to anti-epileptic medications.
Drug Discovery News Placeholder Image

Partners in Parkinson’s

Buck Institute and Q Therapeutics form stem cell collaboration to combat Parkinson’s Disease

Global News

Drug Discovery News Placeholder Image

Collaboration is easy on the eyes

Jerini Ophthalmic and PR Pharmaceuticals to develop sustained-release formulations for eye diseases

Informatics

Drug Discovery News Placeholder Image

VERTICAL*I GOES LATERAL

Company joins forces with Thomson Scientific to provide end-to-end solutions for business development
Drug Discovery News Placeholder Image

Pfizer picks pathway partner

Ingenuity Systems to implement integrated IPA software for pharma giant
Drug Discovery News Placeholder Image

Virtual diabetes research

ADA and Entelos open access to in silico testing with virtual mice

Automation & Instrumentation

Drug Discovery News Placeholder Image

Comprehensive custom services

PerkinElmer, Cerep team up to market assay development, screening services
Drug Discovery News Placeholder Image

A “mito” distribution deal

Invitrogen gets exclusive distribution rights for MitoSciences’ monoclonal antibodies and immunoassays
Drug Discovery News Placeholder Image

Member benefits

Pennsylvania Bio inks supply deal with Fisher Scientific
Drug Discovery News Placeholder Image

ANTIBODY TRANSFER

MitoSciences gains access to University of Oregon’s monoclonal antibody portfolio

Editor's Focus

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue